United States:
The United States corneal transplant market is highly advanced, driven by a well-established healthcare system, extensive donor tissue availability, and significant investments in medical research. The high prevalence of corneal diseases, coupled with strong awareness among patients and healthcare providers, supports market growth. The U.S. market benefits from favorable...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian